Altered effects of potassium channel modulation in the coronary circulation in experimental hypercholesterolemia

V Mathew1, A Lerman

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. mathew.verghese@mayo.edu

Atherosclerosis
|February 13, 2001
PubMed

Insights

Hypercholesterolemia enhances coronary potassium channel function, leading to altered coronary blood flow regulation. This highlights the critical role of potassium channels in managing coronary vasomotor tone during disease.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology
  • Pathophysiology

Background:

  • Potassium (K(+)) channels are crucial for regulating coronary blood flow.
  • Experimental hypercholesterolemia is known to alter coronary vasomotion.
  • The specific role of K(+) channels in hypercholesterolemia-induced changes in coronary blood flow was previously unevaluated.

Purpose of the Study:

  • To investigate the role of potassium channels in regulating coronary hemodynamics in a model of experimental hypercholesterolemia.
  • To assess the impact of hypercholesterolemia on the coronary vasomotor response to specific potassium channel modulators.

Main Methods:

  • Infusion of pinacidil (K(+) channel opener), glibenclamide (K(+) channel blocker), and N-monomethyl-L-arginine (L-NMMA, nitric oxide synthase inhibitor) into the left anterior descending artery of pigs.
  • Comparison of responses before and after 10 weeks of a 2% cholesterol diet.
  • Measurement of coronary blood flow (CBF) and coronary artery diameter (CAD).

Main Results:

  • Intracoronary pinacidil significantly increased CBF and CAD in hypercholesterolemic pigs compared to normolipidemic controls.
  • Intracoronary glibenclamide significantly decreased CBF and CAD in hypercholesterolemic pigs compared to controls.
  • The effect of intracoronary L-NMMA on CBF and CAD was significantly attenuated in hypercholesterolemic pigs.
  • L-NMMA pretreatment did not affect the pinacidil response in normal pigs.

Conclusions:

  • Experimental hypercholesterolemia enhances the functional effects of coronary potassium channel modulation.
  • Basal nitric oxide activity is attenuated in experimental hypercholesterolemia, but this alone does not explain the enhanced potassium channel effects.
  • The potassium channel pathway is critically important for regulating coronary vasomotor tone in pathophysiological conditions like hypercholesterolemia.
Abstract

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...